Cell and gene therapies are reshaping the future of medicine

Cell and gene therapies are reshaping the future of medicine — offering new hope for treating cancer, repairing tissues, and addressing genetic disorders. But scaling these therapies from the lab to real‑world patient care requires one essential ingredient: large volumes of high‑quality cells. And today’s cell manufacturing processes simply aren’t built for that.

Within the NXTGEN Hightech biomedical program, leading Dutch partners are working together to change this. In our latest video, we explore how we’re advancing automated, animal component free, and precisely controlled cell manufacturing technologies that improve consistency, reduce manual labor, and make advanced therapies more accessible.

By overcoming the bottlenecks in today’s cultivation methods, we can accelerate innovation, reduce therapy costs, and bring life‑changing treatments closer to the patients who need them most.